Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Whitney York"'
Publikováno v:
Frontiers in Veterinary Science, Vol 9 (2022)
BackgroundA new, portable bedside coagulation monitor (VCM Vet) has provided a user-friendly, cartridge-based method to perform viscoelastic testing. However, the use of native whole blood limits the time to analyze the sample to minutes. The objecti
Externí odkaz:
https://doaj.org/article/007c60653aa046f7a9a6b5940ff4f7d6
Autor:
Antonio González-Martín, Ursula A Matulonis, Jacob Korach, Mansoor R Mirza, Kathleen N Moore, Xiaohua Wu, Whitney York, Divya Gupta, Stanislav Lechpammer, Bradley J Monk
Publikováno v:
Future Oncology. 18:2505-2536
We reviewed clinical data for niraparib monotherapy in BRCA-mutated ( BRCAm) epithelial ovarian cancer (OC), contextualizing results with data from other poly(ADP-ribose) polymerase inhibitors (PARPis). Niraparib reduced the likelihood of progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdd3996c0b643e0433edaaf09a47143a
https://doi.org/10.2217/fon-2022-0206
https://doi.org/10.2217/fon-2022-0206
Autor:
Johann S. de Bono, Jerry Tolson, Gopinath Ganji, Whitney York, Michele Gorczyca, Sumita Roy-Ghanta, Lakshmi Vasist, Lynn Henson, Ulka N. Vaishampayan, Allan J. Pantuck, Tanya B. Dorff, Ana M. Aparicio, Nancy A. Dawson, Debashis Sarker
Purpose:In patients with metastatic castration-resistant prostate cancer (mCRPC), resistance to androgen receptor (AR)-targeted therapies, such as enzalutamide, remains an issue. Inactivation of inhibitory PTEN activates PI3K/AKT signaling and contri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2379573753118980f3c1fd0dbc3a9767
https://doi.org/10.1158/1078-0432.c.6530454.v1
https://doi.org/10.1158/1078-0432.c.6530454.v1
Autor:
Johann S. de Bono, Jerry Tolson, Gopinath Ganji, Whitney York, Michele Gorczyca, Sumita Roy-Ghanta, Lakshmi Vasist, Lynn Henson, Ulka N. Vaishampayan, Allan J. Pantuck, Tanya B. Dorff, Ana M. Aparicio, Nancy A. Dawson, Debashis Sarker
LLQ=15.6 mg/mL. LLQ shown by horizontal reference line. N=1 for 400 mg GSK2636771 plus 160 mg enzalutamide 160 mg escalation cohort. LLQ, lower limit of quantification.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3623e4cfab7d5deb88a5bd0acf503dff
https://doi.org/10.1158/1078-0432.22480512.v1
https://doi.org/10.1158/1078-0432.22480512.v1
Autor:
Johann S. de Bono, Jerry Tolson, Gopinath Ganji, Whitney York, Michele Gorczyca, Sumita Roy-Ghanta, Lakshmi Vasist, Lynn Henson, Ulka N. Vaishampayan, Allan J. Pantuck, Tanya B. Dorff, Ana M. Aparicio, Nancy A. Dawson, Debashis Sarker
Supplementary Table 1. PCWG2 criteria for progression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34ec8edf76ec138a2ae967b7e7997a85
https://doi.org/10.1158/1078-0432.22480506.v1
https://doi.org/10.1158/1078-0432.22480506.v1
Autor:
Johann S. de Bono, Jerry Tolson, Gopinath Ganji, Whitney York, Michele Gorczyca, Sumita Roy-Ghanta, Lakshmi Vasist, Lynn Henson, Ulka N. Vaishampayan, Allan J. Pantuck, Tanya B. Dorff, Ana M. Aparicio, Nancy A. Dawson, Debashis Sarker
Dashed lines represent 95% confidence intervals. PCWG2, Prostate Cancer Working Group 2; PSA, prostate-specific antigen.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c2817848a536775b6669afde0b01969
https://doi.org/10.1158/1078-0432.22480515
https://doi.org/10.1158/1078-0432.22480515
Autor:
Johann S. de Bono, Jerry Tolson, Gopinath Ganji, Whitney York, Michele Gorczyca, Sumita Roy-Ghanta, Lakshmi Vasist, Lynn Henson, Ulka N. Vaishampayan, Allan J. Pantuck, Tanya B. Dorff, Ana M. Aparicio, Nancy A. Dawson, Debashis Sarker
Supplementary methods: PTEN screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4735cfe1a8cd121c11a18bf841ea0db6
https://doi.org/10.1158/1078-0432.22480509.v1
https://doi.org/10.1158/1078-0432.22480509.v1
Autor:
Johann S. de Bono, Jerry Tolson, Gopinath Ganji, Whitney York, Michele Gorczyca, Sumita Roy-Ghanta, Lakshmi Vasist, Lynn Henson, Ulka N. Vaishampayan, Allan J. Pantuck, Tanya B. Dorff, Ana M. Aparicio, Nancy A. Dawson, Debashis Sarker
B: The dashed line represents 5 CTCs/7.5 mL. C: White circles indicate the location of the lymph node lesion with documented PR, demonstrating a 46% reduction in size from baseline. CT, computerized tomography; CTC, circulating tumor cells; PR, parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2902a7bc0701dd08d35ab5bf7bac965
https://doi.org/10.1158/1078-0432.22480518.v1
https://doi.org/10.1158/1078-0432.22480518.v1
Autor:
Johann S. de Bono, Jerry Tolson, Gopinath Ganji, Whitney York, Michele Gorczyca, Sumita Roy-Ghanta, Lakshmi Vasist, Lynn Henson, Ulka N. Vaishampayan, Allan J. Pantuck, Tanya B. Dorff, Ana M. Aparicio, Nancy A. Dawson, Debashis Sarker
Supplementary Table 2. Summary of serious adverse events.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a9e4994bcd32bf3f650bc9bb6911ec4
https://doi.org/10.1158/1078-0432.22480503.v1
https://doi.org/10.1158/1078-0432.22480503.v1
Autor:
M Kamavra, Antonio Gonzalez-Martin, Bhavana Pothuri, Ignace Vergote, Whitney S Graybill, Mansoor Mirza, Colleen Mccormick, D Lorusso, G Freyer, David O’Malley, Whitney York, Izabela A Malinowska, Bradley Monk
Publikováno v:
E-Posters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89337d5510e2c9fcde8d99fcf97015cf
https://doi.org/10.1136/ijgc-2022-igcs.324
https://doi.org/10.1136/ijgc-2022-igcs.324